You are browsing the archive for Press Release.

by Dana Symons

imaware™ Partners with Rheumatoid Patient Foundation to Promote Awareness and Early Diagnosis of Rheumatoid Arthritis

January 28, 2019 in Awareness, Press Release, RPF News

Makers of at-home health test for RA offer a $10,000 matching grant for Rheumatoid Awareness Day

Houston, TX - January 29, 2019 – imaware™, an at-home testing platform for chronic illness and disease, including rheumatoid arthritis, designed by healthcare company Microdrop, today announced it has partnered with the Rheumatoid Patient Foundation (RPF), working together toward earlier diagnoses and improved patient outcomes.  The newly formed partnership of the at-home testing platform and leading patient advocacy organization for people with rheumatoid disease coincides with the arrival of the 7th annual Rheumatoid Awareness Day on February 2. To further support patients and RPF’s mission, imaware™ is sponsoring Rheumatoid Awareness Day by offering a matching grant for all donations to RPF from now through February 12, 2019, up to $10,000 USD. Donations can be made on the RPF website at: http://rheum4us.org/donate

"RPF's mission is to improve the lives of people with rheumatoid disease,” says RPF Founder and President, Kelly O’Neill Young. “With the medications available today, nothing improves outcomes as much as early diagnosis and treatment. The imaware™ test has the potential to help millions of people have more successful treatment and a better life."

“We believe that the imaware™ at-home rheumatoid arthritis test will help reduce the number of undiagnosed people with RA,” said Jani Tuomi, co-founder, imaware. “With a partner like the Rheumatoid Patient Foundation, we will be able to better engage with the patient community to educate, screen, and ultimately help patients engage their doctors sooner for diagnosis.”

Rheumatoid arthritis, or rheumatoid disease, is a progressive inflammatory disease causing damage to joint and organ tissues, resulting in severe pain, frequent disability, and increased mortality. Rheumatoid Arthritis Day was established in 2013 by the Rheumatoid Patient Foundation as a way to address public lack of understanding of rheumatoid arthritis. The  goal of the partnership is to improve speed-to-diagnosis and treatment to help those impacted by the disease to access treatment faster and improve their health outcomes.

How imaware™ Rheumatoid Arthritis test works:

Three biomarkers commonly associated with Rheumatoid Arthritis are measured: rheumatoid factors (RF) and cyclic citrullinated peptides (CCP) biomarkers. The combination of these biomarkers has been demonstrated to identify the disease in its early development, even before symptoms may show. Available online at imaware.health for $99.00 USD, the test uses a small amount of blood obtained by a finger prick and is collected in a vial. People then mail the sample back in and within five days will receive their confidential test results via a secure portal.  The new imaware™ Rheumatoid Arthritis test expands upon the lineup of Celiac Disease screening and monitoring tests, and is currently available in the United States.

About the Rheumatoid Patient Foundation:
The Rheumatoid Patient Foundation is a 501(c)(3) non-profit organization dedicated to improving the lives of people with rheumatoid disease. RPF was founded in 2011 to address a significant lack of disease education, comparatively low levels of research funding, and difficulty obtaining adequate treatment. RPF is committed to creating pathways to better clinical care and disease outcomes through education, awareness, and patient-centered research. For more information, visit http://rheum4us.org or follow RPF on Facebook or Twitter.

About imaware™

The imaware™ mission is to provide patients with the tools to drive awareness to chronic illness and empower patients to live a better and healthier life - sooner. Each imaware test is designed and validated alongside world-renowned doctors from the most prestigious medical research facilities including Dr. Timothy Niewold, Director of the NYU Colton Center for Autoimmunity, Dr. Kevin Deane, Endowed Chair for Rheumatology Research, University of Colorado Denver, Dr. Stefano Guandalini of the University of Chicago Celiac Disease Center, and Dr. Margaret Spitz and Dr. Melissa Bondy of the Dan L. Duncan Comprehensive Cancer Center at the Baylor College of Medicine.
For more information, visit us online at imaware.health

Comments Off on imaware™ Partners with Rheumatoid Patient Foundation to Promote Awareness and Early Diagnosis of Rheumatoid Arthritis

by Dana Symons

Lamar Advertising Partnering with Rheumatoid Patient Foundation in Support of Rheumatoid Awareness Day

January 23, 2018 in Awareness, Exciting, Press Release, RPF News

 

Outdoor Advertising Company Donating Billboards to Help Organization Raise Awareness and Spur Greater Funding and Research

 

Baton Rouge, LA – January 23, 2018 – Lamar Advertising Company (Nasdaq: LAMR), one of the largest out of home media companies in the world, is supporting Rheumatoid Awareness Day through the donation of more than 200 billboards in 29 states across the country which will feature messaging designed to raise awareness of this life-shortening disease. Taking place on February 2nd, Rheumatoid Awareness Day is designed to address the lack of awareness for rheumatoid disease, a crippling affliction affecting millions. Lamar’s involvement in the effort was initiated by one of its own employees suffering from the disease.

“As a medium, outdoor advertising has tremendous power to drive awareness of important issues and inspire action,” said Barbara Campbell, real estate manager at Lamar Advertising of Milwaukee. “Two million Americans like me suffer from this progressive disease. We are proud to support the Rheumatoid Patient Foundation and join with many of their partners to mark the day and help bolster education efforts that hopefully will lead to earlier diagnoses and better treatments.”

Rheumatoid Awareness Day was created in 2013 to, in part, generate support for increases in much-needed funding for crucial research toward effective treatments and a cure. Rheumatoid Arthritis currently receives only 8% of government funding per patient of comparable diseases. In years past, the organization has primarily used digital channels to spread its message. This year, Lamar is making selected billboards in high-trafficked locations available to help the organization reach a wider and more captive audience.
“We are so grateful for this partnership with Lamar Advertising, which has allowed us to broaden our rheumatoid disease awareness efforts across the country,” said Dana Symons, Vice President of the Rheumatoid Patient Foundation. “Our community has responded with tremendous enthusiasm to the billboards as they help bring this misunderstood and often invisible illness into the public light.”

The billboard creative, designed by the Rheumatoid Patient Foundation, features the faces of actual rheumatoid disease patients who have donated their photos for awareness purposes. The campaign began earlier this month and will culminate on February 2nd.

About Lamar Advertising Company
Founded in 1902, Lamar Advertising Company (Nasdaq: LAMR) is one of the largest outdoor advertising companies in the world, with more than 340,000 displays across the United States, Canada and Puerto Rico. Lamar offers advertisers a variety of billboard, interstate logo and transit advertising formats, helping both local businesses and national brands reach broad audiences every day. In addition to its more traditional out-of-home inventory, Lamar is proud to offer its customers the largest network of digital billboards in the United States with over 2,800 displays. Please feel free to explore our website www.lamar.com or contact us at hello@lamar.com for additional information.

About the Rheumatoid Patient Foundation
The Rheumatoid Patient Foundation is a 501c(3) non-profit organization dedicated to improving the lives of people with rheumatoid disease. RPF was founded in 2011 to address a significant lack of disease education, comparatively low levels of research funding, and difficulty obtaining adequate treatment. RPF is committed to creating pathways to better clinical care and disease outcomes through education, awareness, and patient-centered research. For more information, visit http://rheum4us.org or follow RPF on Facebook or Twitter.

Press Contacts:

Greg Kalish
GK Communications
(917) 592-1942
gkalish@gkcomms.com

Allie McAlpin
Communications Director, Lamar Advertising Company
(225) 926-1000
amcalpin@lamar.com

Dana Symons
Vice President, Rheumatoid Patient Foundation
(616) 443-1998
dana@rheum4us.org

Comments Off on Lamar Advertising Partnering with Rheumatoid Patient Foundation in Support of Rheumatoid Awareness Day

by Dana Symons

RHEUMATOID AWARENESS DAY GAINS MOMENTUM AND INTERNATIONAL RECOGNITION

January 28, 2014 in Events, Exciting, Press Release

rad-ribbon 14

Patients Around the Globe Band Together to Increase Awareness for Rheumatoid Arthritis

January 27, 2014 – Thousands of patients are joining an international movement to increase awareness for the chronic illness known as rheumatoid arthritis, or rheumatoid disease, in anticipation of the second annual Rheumatoid Awareness Day on February 2.

Rheumatoid Awareness Day was established in 2013 by the Rheumatoid Patient Foundation (RPF) to address the lack of awareness for rheumatoid arthritis — often presumed to be a type of arthritis — and resulting inadequacies in disability accommodations, clinical care, healthcare costs and research funding.

This year’s awareness day is expected to have an even larger reach and greater impact. Patients in the U.S. and Canada have already worked within their localities to establish several official proclamations for the observance of Rheumatoid Awareness Day, and local support is being seen across Europe and in New Zealand. “It’s exciting to be contacted by patients, organizations, and even clinicians from around the world asking how they can participate,” says RPF President Kelly Young. Another positive indication that the day is gaining momentum is medical media reaching out. “We know that this is the beginning of something important – something permanent,” says Young; “to bring this invisible disease out of the shadows, driving much needed assistance and research.”

RPF is encouraging individuals and organizations to get involved in the 2014 Rheumatoid Awareness Day by joining the Facebook event created for the day; participating in an online chat on February 2, with Mayo Clinic rheumatologist Dr. John Davis; sharing awareness images and education resources; and creating their own awareness events. RPF is asking participants to share what rheumatoid awareness means to them and to show how they are celebrating awareness by posting photos and personal blogs.

Additionally, Crescendo Bioscience is providing a matching grant for donations to RPF, up to $15,000. Crescendo Bioscience provides quantitative molecular tests and disease information services in the field of rheumatology; it’s initial product is Vectra® DA, the multi-biomarker blood test for rheumatoid arthritis. More information about Rheumatoid Awareness Day and how to be involved can be found at http://rheum4us.org.

About Rheumatoid Arthritis
Rheumatoid arthritis is a progressive inflammatory disease causing damage to joint and organ tissues, resulting in severe pain, frequent disability, and increased mortality. For most patients, current treatments neither relieve all symptoms nor assure a healthy future. Remission is rare[1]. Rheumatoid disease affects about one percent of the world’s population, and Mayo Clinic says lifetime risk of the disease is 3.6 percent for women and 1.7 percent for men[2].

About the Rheumatoid Patient Foundation
RPF is a 501c(3) non-profit organization dedicated to improving the lives of people with rheumatoid diseases such as rheumatoid arthritis and juvenile arthritis. RPF was founded in 2011 to address a significant lack of disease education, comparatively low levels of research funding, and difficulty obtaining adequate treatment. RPF is committed to creating pathways to better clinical care and disease outcomes through education, awareness, and participation in patient-centered research. For more information, visit http://rheum4us.org or follow RPF on Facebook or Twitter.

###

Contact:

Kelly Young
Kelly@rheum4us.org
PO Box 236251
Cocoa, FL 32923

[1] Prince, F et al. Arthritis Research and Therapy. Sustained rheumatoid arthritis remission is uncommon in clinical practice. http://arthritis-research.com/content/pdf/ar3785.pdf
[2] Mayo Clinic. 2011. Mayo Clinic Determines Lifetime Risk of Adult Rheumatoid Arthritis. http://www.ncbi.nlm.nih.gov/pubmed/21360492?dopt=Abstract

Comments Off on RHEUMATOID AWARENESS DAY GAINS MOMENTUM AND INTERNATIONAL RECOGNITION

by KatieB

SURVEY DATA CHALLENGE CONVENTIONAL THINKING OF RHEUMATOID ARTHRITIS AND REVEAL UNRECOGNIZED ASPECTS OF THE DISEASE

October 22, 2013 in Events, Press Release, RPF News

Rheumatoid Patient Foundation to Present Findings at the American College of Rheumatology 2013 Annual Meeting

October 22, 2013 -- The Rheumatoid Patient Foundation (RPF) announced today that it will be presenting two abstracts with compelling findings on the nature and assessment of rheumatoid disease at the 2013 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting, to be held October 25-30 in San Diego, CA. The data, which was collected through large surveys of patients with rheumatoid disease, will be presented by RPF founder and president, Kelly Young, and abstract co-authors in two poster sessions.

Findings to be presented include data on disparities that exist between current medical literature and actual experiences of those living with rheumatoid disease – including the concept of “morning stiffness,” the relationship between swelling and joint damage, and factors that increase or decrease symptoms. Young notes, “An accurate view of patient experiences with the disease is critically important to improving clinical care and discovering better treatments. Our data show a variety of experiences with the disease, which emphasize the importance of clinicians engaging patients to learn about their condition.”

Additional data will be presented examining how the Health Assessment Questionnaire (HAQ) gauges fundamental aspects of rheumatoid disease, including the consequences of physical activity as seen in a real-world context. Young explains, “The HAQ is considered the gold standard in RA assessment, but the data show it may not measure essential aspects of disease impact.”

Details about each of the poster sessions can be found below.

Poster Title: Patient Survey Challenges Conventional Notions Regarding Symptoms and Experiences Of People Living With Rheumatoid Arthritis
Abstract: #2273
Presenter: Young, Kelly O'Neill BA
Co-Authors: Crowson, Cynthia S. MS; Symons, Dana M. BBA
Date: Tuesday, October 29, 2013
Presenter Available: 9:00 am - 11:00 am
Poster Available: 8:30 am - 4:00 pm
Location: Exhibit Hall B2-C-D

 

Poster Title: Patient Survey Regarding Utility Of The Health Assessment Questionnaire Reveals An Unrecognized Aspect Of Disease Activity In Rheumatoid Arthritis: Consequences Of Physical Activity
Abstract: #2272
Presenter: Young, Kelly O'Neill BA
Co-Authors: Symons, Dana M. BBA; Lumpe, Andrew T. PhD; Crowson, Cynthia S. MS
Date: Tuesday, October 29, 2013
Presenter Available: 9:00 am - 11:00 am
Poster Available: 8:30 am - 4:00 pm
Location: Exhibit Hall B2-C-D

 

About the Rheumatoid Patient Foundation
RPF is a 501c(3) non-profit organization dedicated to improving the lives of people with rheumatoid diseases such as rheumatoid arthritis and juvenile arthritis. RPF was founded in 2011 to address a significant lack of disease education, comparatively low levels of research funding, and difficulty obtaining adequate treatment. RPF is committed to creating pathways to better clinical care and disease outcomes through education, awareness, and participation in patient-centered research. For more information, visit http://rheum4us.org or follow RPF on Facebook or Twitter.

Comments Off on SURVEY DATA CHALLENGE CONVENTIONAL THINKING OF RHEUMATOID ARTHRITIS AND REVEAL UNRECOGNIZED ASPECTS OF THE DISEASE

by KatieB

FIRST-EVER RHEUMATOID ARTHRITIS DAY, FEB. 2, BRINGING THOUSANDS TOGETHER

January 31, 2013 in Press Release

FIRST-EVER RHEUMATOID ARTHRITIS DAY, FEB. 2, BRINGING THOUSANDS TOGETHER

Patients Uniting to Overcome Misconceptions; Crescendo Bioscience® to Match Donations to Rheumatoid Patient Foundation

January 31, 2013 – The first-ever Rheumatoid Awareness Day, to be celebrated on Saturday, has already brought thousands of patients together to begin the process of educating the public about rheumatoid arthritis. Almost 6,000 have signed up to recognize the day on the Facebook page for this event, with others preparing to host local events and writing officials requesting recognition of Rheumatoid Awareness Day.

In addition, Crescendo Bioscience®, Inc. is providing a matching grant for donations to the Rheumatoid Patient Foundation (RPF), the group that established Rheumatoid Awareness Day, up to $10,000. RPF encourages both patients and the public to join this first awareness day by donating with the link http://bit.ly/give2RPF. Crescendo Bioscience is a molecular diagnostics company that offers Vectra™ DA, a multi-biomarker blood test that measures disease activity in rheumatoid arthritis patients.

The stories posted on social media have underscored the impact of the disease; some have posted about the career they enjoyed before the disease or about having had the disease since childhood. James posted, “It's such a struggle on a daily basis for those of us with this disease, and to have those around us say, ‘I know how you feel, I've got a little arthritis pain in my finger or toe or wherever.’ This is so much more than just arthritis.”

One goal of this initiative is to overcome the misconception that rheumatoid disease is a form of arthritis. While the disease usually affects joints, the disease process is not the same as osteoarthritis. RPF founder Kelly Young points out, “Joint inflammation is a prominent symptom of this disease for most patients, but it’s a disservice to refer to it as merely a type of arthritis.” She explains, “Just today a patient posted about the severe effects of her rheumatoid lung disease saying her joints feel better than they have in years.”

Rheumatoid arthritis is a progressive inflammatory disease causing damage to joint and organ tissues, resulting in pain, frequent disability, and increased mortality. RPF gives a voice to millions of people with this disease which, despite the lack of awareness, is rather common; Mayo Clinic says lifetime risk of the disease is 3.6 percent for women and 1.7 percent for men.[1]

The Rheumatoid Patient Foundation established Rheumatoid Awareness Day as the second of February, drawing analogies between Groundhog Day and the crucial window of opportunity after disease onset for rheumatoid patients to get early diagnosis and treatment. And it falls during Heart Disease Awareness Month, highlighting the link between rheumatoid disease and heart disease. Rheumatoid patients have a higher incidence of stroke, atrial fibrillation, and silent heart attack. For more information on how to support Rheumatoid Awareness Day, visit http://rheum4us.org/rheumatoid-arthritis-awareness-day/.

About the Rheumatoid Patient Foundation

RPF is a 501c(3) non-profit organization dedicated to improving the lives of people with rheumatoid diseases such as rheumatoid arthritis and juvenile arthritis. RPF was founded in 2011 to address a significant lack of disease education, comparatively low levels of research funding, and difficulty obtaining adequate treatment. RPF is committed to creating pathways to better clinical care and disease outcomes through education, awareness, and participation in patient-centered research. For more information, visit http://rheum4us.org or follow RPF on Facebook or Twitter.

###

[1] Mayo Clinic. 2011. Mayo Clinic Determines Lifetime Risk of Adult Rheumatoid Arthritis. http://www.mayoclinic.org/news2011-rst/6137.html?rss-feedid=1

 

Tags: , 1 Comment »

by KatieB

FIRST AWARENESS DAY FOR RHEUMATOID ARTHRITIS ESTABLISHED BY RHEUMATOID PATIENT FOUNDATION

January 22, 2013 in Events, Exciting, Press Release

Patients Increase Public Awareness of Underestimated Disease

Rheumatoid Arthritis Awareness Day - February 2

Rheumatoid Awareness Day

January 22, 2013 – Rheumatoid Patient Foundation (RPF) announces the establishment of Rheumatoid Awareness Day to be held each year on February 2, giving people with the chronic illness known as rheumatoid arthritis, or rheumatoid disease, a day of recognition. Because the disease is commonly presumed to be a type of arthritis, awareness is lacking, causing problems with disability accommodations, clinical care, healthcare reimbursement and research funding.

February 2 already boasts the observance of Groundhog Day, from which several analogies can be drawn to rheumatoid disease. “Compare disease onset to the moment the groundhog comes out of his hole to look for his shadow,” says Kelly Young, founder of the RPF. “It’s impossible to predict how aggressive the disease will be or whether treatments will be effective. The six weeks that the groundhog forecasts correspond to the short window of opportunity for people with rheumatoid disease to get early diagnosis and treatment, which has been shown to be a crucial component of positive outcome.”

Rheumatoid arthritis is a progressive inflammatory disease causing damage to joint and organ tissues, resulting in severe pain, frequent disability, and increased mortality. For most patients, current treatments neither relieve all symptoms nor assure a healthy future. Remission is rare[1]. Rheumatoid disease affects about one percent of the world’s population, with 1.6 to 2 million Americans currently diagnosed. Mayo Clinic says lifetime risk of the disease is 3.6 percent for women and 1.7 percent for men[2].

Rheumatoid Awareness Day comes at the start of Heart Disease Awareness month, underscoring a serious aspect of rheumatoid disease: heart involvement. Studies show that rheumatoid disease may affect the heart prior to diagnosis[3]. Rheumatoid patients have higher incidence of stroke and atrial fibrillation[4] in addition to the specific effects of the disease upon the heart itself[5]. A study conducted by Mayo Clinic[6] reported that rheumatoid arthritis patients were twice as likely to experience silent heart attacks and sudden cardiac deaths.

The Rheumatoid Patient Foundation will support the first annual Rheumatoid Awareness Day with a campaign aimed at raising awareness and educating about rheumatoid disease. RPF encourages both the rheumatoid patient community and the public to get involved by sharing educational resources, promoting awareness messages via social media, participating in a live online chat and a matching donation opportunity. For information on how to support Rheumatoid Awareness Day, visit http://rheum4us.org/rheumatoid-arthritis-awareness-day/.

Rheumatoid Patient Foundation

RPF is a 501c(3) non-profit organization dedicated to improving the lives of people with rheumatoid diseases such as rheumatoid arthritis and juvenile arthritis. RPF was founded in 2011 to address significant lack of disease education, comparatively low levels of research funding, and difficulty obtaining adequate treatment. RPF is committed to creating pathways to better clinical care and disease outcomes through education, awareness, and participation in patient-centered research. For more information, visit http://rheum4us.org or follow us on Facebook http://www.facebook.com/rheumatoidpatientfoundation or Twitter http://www.twitter.com/RheumPF.

###

Contact:

Kelly Young
Kelly@rheum4us.org
PO Box 236251
Cocoa, FL 32923

[1] Prince, F et al. Arthritis Research and Therapy. Sustained rheumatoid arthritis remission is uncommon in clinical practice. http://arthritis-research.com/content/pdf/ar3785.pdf

[2] Mayo Clinic. 2011. Mayo Clinic Determines Lifetime Risk of Adult Rheumatoid Arthritis. http://www.mayoclinic.org/news2011-rst/6137.html?rss-feedid=1

[3] Kerola, A et al. Annals of Rheumatic Diseases. 2012. Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis. http://ard.bmj.com/content/early/2012/11/22/annrheumdis-2012-202398.abstract

[4] Jesper, L et al. British Medical Journal. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. http://www.bmj.com/content/344/bmj.e1257

[5] Young, K. 2011. Rheumatoid Arthritis Warrior. 20 Facts About Rheumatoid Heart Disease. http://rawarrior.com/20-facts-about-rheumatoid-heart-disease/

[6] Science Daily. 2005. Mayo Clinic Finds Rheumatoid Arthritis Patients At Higher Risk For Unrecognized Heart Disease And Cardiac Sudden Death. http://www.sciencedaily.com/releases/2005/02/050204121639.htm

11 Comments »

MENU
Rheumatoid Patient Foundation